H.C. Wainwright analyst Joseph Pantginis maintained a Hold rating on Humanigen (HGEN - Research Report) today. The company's shares closed yesterday at $0.22.According to TipRanks, Pantginis is an analyst with an average return of -20.0% and a 26.30% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Humanigen, Astria Therapeutics, and Celldex.The word on The Street in general, suggests a Hold analyst consensus rating for Humanigen with a $1.50 average price target.See today’s best-performing stocks on TipRanks >>Based on Humanigen's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $1.04 million and a GAAP net loss of $30.15 million.
https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-hold-on-humanigen-hgen?utm_source=advfn.com&utm_medium=referral
Humanigen (NASDAQ:HGEN)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Humanigen Charts.
Humanigen (NASDAQ:HGEN)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Humanigen Charts.